AlTi Global Inc. Takes Position in Celcuity, Inc. $CELC

AlTi Global Inc. acquired a new position in shares of Celcuity, Inc. (NASDAQ:CELC) during the third quarter, HoldingsChannel reports. The firm acquired 5,287 shares of the company’s stock, valued at approximately $261,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Atle Fund Management AB bought a new position in shares of Celcuity during the third quarter worth approximately $1,836,000. New York State Common Retirement Fund boosted its stake in shares of Celcuity by 68.0% in the third quarter. New York State Common Retirement Fund now owns 47,704 shares of the company’s stock valued at $2,357,000 after buying an additional 19,313 shares during the period. Nisa Investment Advisors LLC grew its position in Celcuity by 2,142.0% during the third quarter. Nisa Investment Advisors LLC now owns 15,627 shares of the company’s stock worth $772,000 after buying an additional 14,930 shares in the last quarter. Saturn V Capital Management LP increased its stake in Celcuity by 8.4% during the 2nd quarter. Saturn V Capital Management LP now owns 1,185,520 shares of the company’s stock worth $15,827,000 after acquiring an additional 91,843 shares during the period. Finally, Candriam S.C.A. raised its holdings in Celcuity by 48.3% in the 3rd quarter. Candriam S.C.A. now owns 390,924 shares of the company’s stock valued at $19,312,000 after acquiring an additional 127,348 shares in the last quarter. 63.33% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Celcuity

In other news, Director David Dalvey sold 20,000 shares of the company’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $120.03, for a total value of $2,400,600.00. Following the sale, the director directly owned 90,000 shares in the company, valued at $10,802,700. This represents a 18.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard E. Buller sold 3,900 shares of the company’s stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $96.73, for a total transaction of $377,247.00. Following the transaction, the director directly owned 7,260 shares in the company, valued at $702,259.80. The trade was a 34.95% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 26,900 shares of company stock valued at $3,094,917 over the last 90 days. Insiders own 15.77% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Wolfe Research initiated coverage on Celcuity in a research report on Tuesday, November 18th. They issued an “outperform” rating and a $110.00 price target on the stock. Stifel Nicolaus upped their price objective on Celcuity from $68.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Craig Hallum upped their price objective on shares of Celcuity from $96.00 to $108.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Jefferies Financial Group raised their price target on shares of Celcuity from $108.00 to $134.00 and gave the company a “buy” rating in a research note on Tuesday, December 2nd. Finally, Needham & Company LLC set a $95.00 target price on Celcuity in a report on Monday, October 20th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $105.25.

Celcuity Stock Up 0.1%

Shares of Celcuity stock opened at $104.23 on Thursday. The company has a debt-to-equity ratio of 2.74, a quick ratio of 12.26 and a current ratio of 12.26. The firm has a fifty day moving average of $105.43 and a two-hundred day moving average of $77.36. Celcuity, Inc. has a one year low of $7.57 and a one year high of $120.32. The company has a market cap of $4.82 billion, a P/E ratio of -28.40 and a beta of 0.36.

Celcuity (NASDAQ:CELC) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.92) EPS for the quarter, beating the consensus estimate of ($1.05) by $0.13. On average, analysts forecast that Celcuity, Inc. will post -2.62 earnings per share for the current year.

Celcuity Company Profile

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.